<?xml version="1.0" encoding="UTF-8"?>
<p>Evidence of COVID-19-associated increases in circulating cardiac troponin T (cTnT) and cardiac troponin I (cTnI) above the 99th percentile reference limit are emerging in the literature.
 <sup>
  <xref rid="bibr14-0004563220921888" ref-type="bibr">14</xref>
  <xref rid="bibr15-0004563220921888" ref-type="bibr"/>
  <xref rid="bibr16-0004563220921888" ref-type="bibr"/>–
  <xref rid="bibr17-0004563220921888" ref-type="bibr">17</xref>
 </sup> Detectable cTnI has been observed in most COVID-19 patients. In a retrospective cohort analysis, cTnI was significantly elevated in 54 subjects who died compared with 137 survivors (median [IQR] cTnI 22 [5.6–83.1] ng/L vs. 3 [1.1–5.5] ng/L, 
 <italic>P</italic>≤0.0001).
 <sup>
  <xref rid="bibr18-0004563220921888" ref-type="bibr">18</xref>
 </sup>
</p>
